Novartis AG (NOVN.SW)

CHF 88.04

(-0.77%)

Net Debt Summary of Novartis AG

  • Novartis AG's latest annual net debt in 2023 was 12.95 Billion USD , down -36.64% from previous year.
  • Novartis AG's latest quarterly net debt in 2024 Q3 was 16.7 Billion USD , down -12.02% from previous quarter.
  • Novartis AG reported annual net debt of 20.44 Billion USD in 2022, up 9.42% from previous year.
  • Novartis AG reported annual net debt of 18.68 Billion USD in 2021, down -34.18% from previous year.
  • Novartis AG reported quarterly net debt of 16.7 Billion USD for 2024 Q3, down -12.02% from previous quarter.
  • Novartis AG reported quarterly net debt of 17.81 Billion USD for 2024 Q1, up 37.51% from previous quarter.

Annual Net Debt Chart of Novartis AG (2023 - 1998)

Historical Annual Net Debt of Novartis AG (2023 - 1998)

Year Net Debt Net Debt Growth
2023 12.95 Billion USD -36.64%
2022 20.44 Billion USD 9.42%
2021 18.68 Billion USD -34.18%
2020 28.39 Billion USD 55.81%
2019 18.22 Billion USD -3.18%
2018 18.81 Billion USD -3.81%
2017 19.56 Billion USD 16.49%
2016 16.79 Billion USD -2.68%
2015 17.25 Billion USD 133.58%
2014 7.38 Billion USD -34.8%
2013 11.33 Billion USD -20.06%
2012 14.17 Billion USD -14.04%
2011 16.49 Billion USD -6.43%
2010 17.62 Billion USD 60.01%
2009 11.01 Billion USD 120.41%
2008 4.99 Billion USD 2044.64%
2007 233 Million USD -93.15%
2006 3.4 Billion USD 80.14%
2005 1.88 Billion USD 297.47%
2004 475 Million USD 371.43%
2003 -175 Million USD 23.25%
2002 -228 Million USD 89.45%
2001 -2.16 Billion USD -29.25%
2000 -1.67 Billion USD -172.98%
1999 2.29 Billion USD 94.95%
1998 1.17 Billion USD 0.0%

Peer Net Debt Comparison of Novartis AG

Name Net Debt Net Debt Difference
Roche Holding AG 25.4 Billion CHF 49.008%
Roche Holding AG 25.4 Billion CHF 49.008%